Keith Gollust Net Worth & Insider Trades

Keith Gollust - Director, Synta Pharmaceuticals Corp

As of December 15, 2015

What is Keith Gollust's Net Worth?

The current estimated net worth of Synta Pharmaceuticals Corp's Director, Keith Gollust, is estimated to be about $6.09M . Keith Gollust owns about 1,714,169 units of Synta Pharmaceuticals Corp common stock. In the last 8 years at Synta Pharmaceuticals Corp, Keith Gollust has sold an estimated value of $534.24K worth.

What is Keith Gollust's Past Insider Trading?

Keith Gollust's largest purchase order was 418,311 units , worth over $1.8M on February 13, 2007. Keith Gollust's largest sale order was 745,892 units , worth over $285.12K on December 9, 2015. In total, Keith Gollust has made about 26 transactions over 8 years of their time at Synta Pharmaceuticals Corp. Keith Gollust usually trades in July, with the busiest year in 2015. The most recent transaction was a sale order of 600,000 units , worth over $207.72K on December 15, 2015.

Keith Gollust

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Keith Gollust's' Mailing Address?

  • Mailing address is C/o Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421 MA

What are Synta Pharmaceuticals Corp's Past Insider Trades?

Synta Pharmaceuticals Corp's most recent insider trade came on December 15, 2015 by Keith Gollust who sold 600,000 units worth $207.72K . In the last 8 years, insiders at Synta Pharmaceuticals Corp have sold an estimated value of $8.52M and bought an estimated value of $145.31M worth of shares. Insider trading is most common in July, with the busiest year in 2012. The most active traders at the company are Bruce Kovner, Director,  Keith Gollust, Director,  and Safi Bahcall, President and CEO .

SYNTA PHARMACEUTICALS CORP Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1